An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Depression in Adults with a Chronic Physical Health Problem: Treatment and Management.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society (UK); 2010. (NICE Clinical Guidelines, No. 91.)
Top results in this bookTable of Contents
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Coeliac Disease: Recognition, Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2015 Sep. (NICE Guideline, No. 20.)
Fractures (Non-Complex): Assessment and Management.
National Clinical Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Feb. (NICE Guideline, No. 38.)
World Report on Disability 2011.
Geneva: World Health Organization; 2011.
Emergency and acute medical care in over 16s: service delivery and organisation.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Mar. (NICE Guideline, No. 94.)
Bimekizumab (Bimzelx): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with active psoriatic arthritis. Bimekizumab can be used alone or in combination with a conventional non-biologic disease-modifying antirheumatic drug (e.g., methotrexate) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jun.
Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes.
NICE Medicines and Prescribing Centre (UK).
Manchester: National Institute for Health and Care Excellence (NICE); 2015 Mar. (NICE Guideline, No. 5.)
Cystic Fibrosis: Diagnosis and management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2017 Oct 25. (NICE Guideline, No. 78.)
Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence [Internet].
National Collaborating Centre for Primary Care (UK).
London: Royal College of General Practitioners (UK); 2009 Jan. (NICE Clinical Guidelines, No. 76.)
CADTH Canadian Drug Expert Committee Recommendation: Ixekizumab (Taltz — Eli Lilly Canada Inc.): Indication: Adult patients with active psoriatic arthritis (PsA) who have responded inadequately to, or are intolerant to one or more disease-modifying antirheumatic drugs (DMARD) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Aug.
Guselkumab (Tremfya): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with active psoriatic arthritis. Guselkumab can be used alone or in combination with a conventional disease modifying antirheumatic drug (e.g., methotrexate) [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Dec.
Multimorbidity: Assessment, Prioritisation and Management of Care for People with Commonly Occurring Multimorbidity.
London: National Institute for Health and Care Excellence (NICE); 2016 Sep. (NICE Guideline, No. 56.)
Rheumatoid arthritis in adults: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2018 Jul 11. (NICE Guideline, No. 100.)
Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd edition.
Geneva: World Health Organization; 2013.
Osteoarthritis: care and management.
London: National Institute for Health and Care Excellence (NICE); 2020 Dec 11. (NICE Clinical Guidelines, No. 177.)
Spondyloarthritis in over 16s: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2017 Jun. (NICE Guideline, No. 65.)
Physical Health of People in Prison: Assessment, Diagnosis and Management of Physical Health Problems.
London: National Institute for Health and Care Excellence (NICE); 2016 Nov. (NICE Guideline, No. 57.)
CADTH Canadian Drug Expert Committee Recommendation: Baricitinib (Olumiant — Eli Lilly Canada Inc.): Indication: For use in combination with methotrexate (MTX) for the treatment of adult patients with moderate to severe rheumatoid arthritis (RA) who have responded inadequately to one or more disease-modifying anti-rheumatic drugs (DMARDs). Baricitinib may also be used as monotherapy in cases of intolerance to MTX [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Aug.
Treating Substance Use Disorder in Older Adults: Updated 2020 [Internet].
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2020. (Treatment Improvement Protocol (TIP) Series, No. 26.)
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on